The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Researchers conducted a retrospective study published in June 2025 issue of Rheumatology International to compile evidence on sex-specific differences in systemic lupus erythematosus (SLE), focusing ...